Zeiss LSM900 Service Maintenance Contract

The Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) owns a Carl Zeiss LSM900 confocal imaging system (s/n 2901000217) for fluorescence microscopy. The current maintenance contract for this system expired in 2025. The Zeiss 900 imaging system is heavily used at White Oak FDA campus as a scientific tool in CBER’s research programs to support CBER investigators. To minimize system downtime, CBER requires a service agreement for maintenance and possible repair.